Despite not reaching statistical significance (set at p > 0.05), SSc patients exhibited a tendency to present an increased percentage of early-activated cells (CD25+) among T17-like, T1/17-like, CXCR3−CCR6−, and CD4+CD8+ Tf cells. The gene discussed is CD4; the disease is systemic sclerosis.